Investors eyeing a purchase of Arcturus Therapeutics Holdings Inc (ARCT) stock, but cautious about paying the going market price of $21.45/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2025 put at the $17.50 strike, which has a bid at the time of this writing of $2.20..